It is darkest before the dawn
So what was the big surprise? The loss of 7m for Q3 and 14,3m for 9months, combined with the information about the need for additional funding. That was enough for the market to give up on the C-rad case for this time… more about this later but first the important part of the report! Focus on the main thing! The most important number for C-rad is the order intake. 23m was at the low end of the range, the market was expecting +50% so we should be around 25/26m, but have in mind q3 2014 was strong and most likely the Skandion order was sold at a discount. Skandion is important from a strategic perspective so that can explain the missing 2m and also explain the low gross margin, 53% for 9 months is not what we are used to. Anyway this was the second best quater in C-rads history and 2-3m represents one project that was pushed into Q4, so not the end of the world… its impressive to see the DACH region (Deutschland, Austria and Switzerland) marching on, the ROE (Italy) is growing, the US is on track and thanks to the Skandion order the Nordic region shows a strong development. The weak areas are clearly Asia, OEM and Cyrpa. ...